News
HTFL
29.35
+1.84%
0.53
Weekly Report: what happened at HTFL last week (0803-0807)?
Weekly Report · 1d ago
JPMorgan Chase CEO Jamie Dimon Says AI 'Will Cure Cancers' — But How Should You Invest?
Barchart · 08/04 13:15
Weekly Report: what happened at HTFL last week (0727-0731)?
Weekly Report · 08/03 09:00
Roblox downgraded, Quanta Services upgraded: Wall Street’s top analyst calls
TipRanks · 07/31 13:50
This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Benzinga · 07/31 13:12
Heartflow Price Target Announced at $34.00/Share by Baird
Dow Jones · 07/31 09:35
Baird Initiates Coverage On HeartFlow with Outperform Rating, Announces Price Target of $34
Benzinga · 07/31 09:25
Heartflow initiated with an Outperform at Baird
TipRanks · 07/31 08:30
Weekly Report: what happened at HTFL last week (0720-0724)?
Weekly Report · 07/27 09:00
These healthcare stocks are trading near oversold levels as earnings season picks up
Seeking Alpha · 07/21 12:54
NZS Growth Equity adds Nvidia, boosts stakes in ASML and Axon among Q2 moves
Seeking Alpha · 07/20 17:55
Weekly Report: what happened at HTFL last week (0713-0717)?
Weekly Report · 07/20 09:00
Analysts Conflicted on These NA Names: HeartFlow, Inc. (HTFL), Phoenix Education Partners, Inc. (PXED) and Veradermics, Incorporated (MANE)
TipRanks · 07/15 13:40
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
The Motley Fool · 07/15 12:30
Weekly Report: what happened at HTFL last week (0706-0710)?
Weekly Report · 07/13 09:00
Brandon Vazquez Reiterates Buy on HeartFlow, Citing Strengthening Product Portfolio, Clinical Validation, and Long-Term Growth Potential
TipRanks · 07/13 08:15
HeartFlow Sees Insider Stock Selling
Simply Wall St · 07/12 12:03
HeartFlow: A Premium AI Diagnostics Story
Seeking Alpha · 07/12 03:10
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
The Motley Fool · 07/08 21:41
Weekly Report: what happened at HTFL last week (0629-0703)?
Weekly Report · 07/06 09:00
More
Webull provides a variety of real-time HTFL stock news. You can receive the latest news about HEARTFLOW INC through multiple platforms. This information may help you make smarter investment decisions.
About HTFL
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.